Oct 01, 2019
SaVida Health, a Leading Provider of Outpatient Opioid and Alcohol Addiction Treatment Services, Opens in West Springfield, MA
Jul 30, 2019
The Government of Canada increases access to treatment for opioid use disorder in Alberta
Apr 13, 2019
Continuum Recovery Center in Arizona is the First to Offer Patients the Bridge Device for Opioid Detox
Feb 20, 2019
Indivior Announces Launch of SUBOXONE® (buprenorphine and naloxone) Sublingual Film Authorized Generic
Feb 19, 2019
Sandoz Inc. launches authorized generic version of buprenorphine and naloxone sublingual film
Feb 19, 2019
Kirkbride Center Expands Capacity to Respond to Opioid Crisis
Jan 07, 2019
Positive Results From Human PK Study Assessing Orexo's New Intranasal Naloxone Formulations for Opioid Overdose Reversal
Dec 20, 2018
Aquestive Therapeutics Provides End of Year Business Update, Including Progress of its Proprietary CNS Assets, Financial and Legal Matters
Dec 18, 2018
Indivior Provides Legal and Trading Update; Confirms Launch of PERSERIS(TM) and Key Elements of Contingency Plan
Dec 12, 2018
Court of Appeals for the Federal Circuit Declines to Immediately Issue Mandate After Preliminary Injunction Ruling
Oct 09, 2018
Q2i's New MATRA Technology Enables Earliest Interventions to Improve Recovery from Opioid Use Disorder
Sep 06, 2018
Maine-Based Door to Door Doctors Deploys Q2i's OARS Technology to Support Patients Recovering from Opioid Use Disorder
Sep 04, 2018
US WorldMeds And Salix Pharmaceuticals To Highlight Clinical Data For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine) At 2018 PAINWeek Conference
Jul 31, 2018
Indivior Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film Upheld
Jul 10, 2018
Inspire Malibu Announces Breakthrough Addiction Detox Treatment for Heroin and Opioids
Jun 15, 2018
Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market
Jun 14, 2018
FDA approves first generic versions of Suboxone sublingual film, which may increase access to treatment for opioid dependence
May 31, 2018
Indivior Receives Subpoena from California Department of Insurance
May 14, 2018
Indivior Enters into Settlement with Par Pharmaceutical in Patent Infringement Case
Feb 08, 2018
Indivior Files Complaints Asserting New SUBOXONE® Film Patent Against ANDA-filers